ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2020
Characterization of a highly effective preparation for suppression of myocardial glucose utilization.
Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Pooled it
- Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical Trial.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Trial
- Article
- Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level.EJNMMI research · 2024Article
- Inflammation and Myocardial Blood Flow in Cardiac Sarcoidosis.Current cardiology reports · 2024Review
- Diagnostic yield of whole-bodyJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Utility of serum ketone levels for assessment of myocardial glucose suppression forJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Effective suppression of myocardial glucose uptake using predesigned low-carbohydrate boxed meals.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Tracking the progress of inflammation with PET/MRI in a canine model of myocardial infarction.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022Article
- Review
- Clinical Features and Diagnosis of Cardiac Sarcoidosis.Journal of clinical medicine · 2021Review
- Correlating cardiac F-18 FDG PET/CT results with intra-operative findings in infectious endocarditis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021Article
- Hybrid PET/MR imaging in myocardial inflammation post-myocardial infarction.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020Review
- Suppression of myocardial glucose metabolism in FDG PET/CT: impact of dose variation in heparin bolus pre-administration.European journal of nuclear medicine and molecular imaging · 2020Article
- Diagnostic Performance ofDiagnostics (Basel, Switzerland) · 2020Article
- Seeking clarity: Insights from a highly effective preparation protocol for suppressing myocardial glucose uptake for PET imaging of cardiac inflammation.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020Article
- Radionuclide Imaging for Cardiac Sarcoidosis: Much Potential Benefit, but Still Much to Do.Annals of nuclear cardiology · 2020Review
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
Abstract
backgroundWith appropriate protocols, F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) can visualize myocardial inflammation. Optimal protocols and normative myocardial FDG uptake values are not well-established.
methodsWe evaluated 111 patients referred for inflammation cardiac FDG PET/CT. Patients followed a low-carbohydrate, high-fat diet for 36 hours before imaging and received unfractionated heparin. Glucose and fatty acid metabolism biomarkers were obtained. Mean blood pool and maximum myocardial uptake (SUV
resultsAdequate suppression of myocardial FDG uptake occurred in 95% of patients (n = 106). Myocardial SUV
conclusionsPatients following intensive metabolic preparation have myocardial FDG SUV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.